TrialClinical drug investigation2009

Triptorelin 6-month formulation in the management of patients with locally advanced and metastatic prostate cancer: an open-label, non-comparative, multicentre, phase III study.

Eija A Lundström et al.PubMed ↗Publisher ↗

No numbers read from the abstract.